Company to commence initial commercial launch of catheter control technology in the United States immediately
By RBR Staff
June 04, 2012
Hansen Medical, Inc., a developer of robotic technology for accurate 3D control of catheter movement, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Magellan Robotic System, including the catheter and accessories. The Company will commence commercialization at selected centers in the U.S. immediately, with a full launch expected later in the year. The product will be presented at the 66th Vascular Annual Meeting of the Society for Vascular Surgery at National Harbor, Maryland from June 7-9.
The global vascular market is large and expanding rapidly, driven by an aging population, the prevalence…
This is a preview article. Please register to view the entire article.